Journal Watch · Frontiers in Immunology · 2026

Phagocytic aberrations in macrophages in asthma: a mechanistic systematic review integrating <i>in vitro</i>, animal, and human evidence.

Systematic integration of these mechanisms enhances the understanding of innate immune dysfunction in asthma and provides a theoretical basis for developing therapeutic strategies targeting macrophage phagocytic function.<h4>Systematic review registration</h4>https://www.crd.york.ac.uk/prospero/, identifier CRD420261332569.

Bai S, Gao Y, Sun Z et al.Frontiers in Immunology3 min readPharma relevance 40/100

DOI: 10.3389/fimmu.2026.1844956PMID: 42382752Study type: meta-analysis / systematic review

TL;DR

Systematic integration of these mechanisms enhances the understanding of innate immune dysfunction in asthma and provides a theoretical basis for developing therapeutic strategies targeting macrophage phagocytic function.<h4>Systematic review registration</h4>https://www.crd.york.ac.uk/prospero/, identifier CRD420261332569.

Key findings

  • Based on the included studies, the relevant mechanisms were categorized into eight categories: dysregulation of phagocytic receptor signaling; defects at various stages of efferocytosis; immunometabolic reprogramming; aberrant signal transduction; regulation by immunomodulatory factors; acquired alterations in cellular function; circadian clock regulation; and other unclassified mechanisms.<h4>Conclusion</h4>Phagocytic aberrations in macrophages in asthma represent a complex process driven by a multi-layered, interconnected molecular network.
  • These aberrations contribute to the persistence of chronic airway inflammation, increased susceptibility to infection, elevated risk of acute exacerbations, and the development of severe or refractory asthma.
  • Systematic integration of these mechanisms enhances the understanding of innate immune dysfunction in asthma and provides a theoretical basis for developing therapeutic strategies targeting macrophage phagocytic function.<h4>Systematic review registration</h4>https://www.crd.york.ac.uk/prospero/, identifier CRD420261332569.

What they did

Two independent reviewers performed screening, data extraction, and quality assessment. Due to substantial heterogeneity across studies, a narrative synthesis approach was used to integrate the evidence.<h4>Results</h4>A total of 37 studies, published between 1982 and 2025, were ultimately included. Overall, macrophage phagocytic function in asthma is characterized by aberrations dependent on clinical phenotype, phagocytic substrate, and the microenvironment.

Full abstract (original)

Background: <h4>Objective</h4>To integrate evidence from human, animal, and <i>in vitro</i> studies to elucidate the molecular mechanisms underlying phagocytic aberrations in asthmatic macrophages and to construct a cross-hierarchical mechanistic framework.<h4>Methods</h4>This systematic review followed the PRISMA 2020 statement. PubMed and Web of Science Core Collection were searched from inception to March 6, 2026. We included original human, animal, and cellular studies on asthma that investigated macrophage phagocytic function and reported related molecular mechanisms.

What they did: Two independent reviewers performed screening, data extraction, and quality assessment. Due to substantial heterogeneity across studies, a narrative synthesis approach was used to integrate the evidence.<h4>Results</h4>A total of 37 studies, published between 1982 and 2025, were ultimately included. Overall, macrophage phagocytic function in asthma is characterized by aberrations dependent on clinical phenotype, phagocytic substrate, and the microenvironment.

Results & conclusions: Based on the included studies, the relevant mechanisms were categorized into eight categories: dysregulation of phagocytic receptor signaling; defects at various stages of efferocytosis; immunometabolic reprogramming; aberrant signal transduction; regulation by immunomodulatory factors; acquired alterations in cellular function; circadian clock regulation; and other unclassified mechanisms.<h4>Conclusion</h4>Phagocytic aberrations in macrophages in asthma represent a complex process driven by a multi-layered, interconnected molecular network. These aberrations contribute to the persistence of chronic airway inflammation, increased susceptibility to infection, elevated risk of acute exacerbations, and the development of severe or refractory asthma. Systematic integration of these mechanisms enhances the understanding of innate immune dysfunction in asthma and provides a theoretical basis for developing therapeutic strategies targeting macrophage phagocytic function.<h4>Systematic review registration</h4>https://www.crd.york.ac.uk/prospero/, identifier CRD420261332569.

Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1844956 · PubMed 42382752.

Why it matters for pharma & biotech

  • Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • As a review, this paper synthesises prior studies rather than reporting new experimental data; weight it accordingly.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Frontiers in Immunology study find?

Systematic integration of these mechanisms enhances the understanding of innate immune dysfunction in asthma and provides a theoretical basis for developing therapeutic strategies targeting macrophage phagocytic function.<h4>Systematic review registration</h4>https://www.crd.york.ac.uk/prospero/, identifier CRD420261332569.

What type of study is this?

It is a meta-analysis / systematic review, published in Frontiers in Immunology in 2026. Two independent reviewers performed screening, data extraction, and quality assessment.

Where can I read the original paper?

The original is at the publisher via DOI 10.3389/fimmu.2026.1844956. PubMed ID: 42382752. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Bai S, Gao Y, Sun Z et al.. Phagocytic aberrations in macrophages in asthma: a mechanistic systematic review integrating &lt;i&gt;in vitro&lt;/i&gt;, animal, and human evidence.. Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1844956.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/phagocytic-aberrations-in-macrophages-in-asthma-a-mechanistic-systematic-844956/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides